3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
2
Uterine Cervical Neoplasms
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
9
Oxaliplatin
6
Cisplatin
6
Capecitabine
6
durvalumab
4
apatinib
4
S 1 (combination)
4
Irinotecan
4
Immune Checkpoint Inhibitors
4
surufatinib
3
Injections
3
Drug Therapy
3
pembrolizumab
2
lenvatinib
2
camrelizumab
2
Taxes
2
Leucovorin
2
Fluorouracil
2
Docetaxel
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
toripalimab
1
taxane
1
spartalizumab
1
sintilimab
1
regorafenib
1
manganese chloride
1
irinotecan sucrosofate
1
gimeracil
1
gemcitabine-oxaliplatin regimen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Biliary Tract Neoplasms
×
taxane
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled